Dirnhofer and associates [12] found that: Overall, trophoblastic hormone immunoreactivity in 36% of transitional cell carcinoma, and detailed analysis showed 35 % hCGbeta, 17% hCGbetacf, 9% hCGalpha, 4% HCG, and 2% hPL-positive cases. Here, LGALS1 is linked to transitional cell carcinoma.